Metin Kurtoglu
Chief Technology Officer · Cartesian Therapeutics, Inc.
- 2024
- Dec 11, 2024
- 3
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Metin Kurtoglu. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Timothy A. Springer - $14.15M in RNAC purchases and sales on record
- Milos Miljkovic - $908K in RNAC purchases and sales on record
- Christopher M. Jewell - $875K in RNAC purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Metin Kurtoglu?
Metin Kurtoglu is a corporate insider, tracked as Chief Technology Officer of Cartesian Therapeutics, Inc. (RNAC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Metin Kurtoglu last file a Form 4?
The most recent primary Form 4 on record is dated 11 December 2024, one of 3 filings going back to 2024.
Has Metin Kurtoglu been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($2.43M) across all tracked filings.
